Background: COVID-19 disease-related coagulopathy and thromboembolic complication, an important aspect of the disease pathophysiology, are frequent and associated with poor outcomes, particularly significant in hospitalized patients. Undoubtedly, anticoagulation forms a cornerstone for the management of hospitalized COVID-19 patients, but the appropriate dosing has been inconclusive and a subject of research. We aim to review existing literature and compare safety and efficacy outcomes of prophylactic and therapeutic dose anticoagulation in such patients.
View Article and Find Full Text PDF(SL) is a well-known skin commensal. It is coagulase-negative bacteria that has often been labeled as a contaminant. While coagulase-negative bacteria are not as virulent as aureus, there has been an increasing trend for this organism to be associated with complications commonly known to occur with its more aggressive counterpart.
View Article and Find Full Text PDFClinicians and pathologists must be aware of the occurrence of Kikuchi-Fujimoto Disease, as one of the differential diagnoses of cervical lymphadenopathy.
View Article and Find Full Text PDFSystemic lupus erythematosus (SLE) has been known to have various degrees of cardiac involvement. However, limited evidence exists on prevalence of heart rhythm disorders in patients with SLE who have subsequent pacemaker (PM) implantation. The purpose of this study was to examine the prevalence of sinus node dysfunction (SND) in patients with SLE.
View Article and Find Full Text PDF